25-hydroxyvitamin D, Fibroblast Growth Factor 23, and Risk of Acute Kidney Injury Over 20 Years of Follow-Up

Pavkov, 2018, Trends in hospitalizations for acute kidney injury — United States, 2000–2014, MMWR Morb Mortal Wkly Rep, 67, 289, 10.15585/mmwr.mm6710a2 Sawhney, 2017, Epidemiology of AKI: utilizing large databases to determine the burden of AKI, Adv Chronic Kidney Dis, 24, 194, 10.1053/j.ackd.2017.05.001 Coca, 2012, Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis, Kidney Int, 81, 442, 10.1038/ki.2011.379 Wald, 2009, Chronic dialysis and death among survivors of acute kidney injury requiring dialysis, JAMA, 302, 1179, 10.1001/jama.2009.1322 Coca, 2009, Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis, Am J Kidney Dis, 53, 961, 10.1053/j.ajkd.2008.11.034 2012, KDIGO clinical practice guideline for acute kidney injury, Kidney Int Suppl, 2, 1 Azak, 2013, Effect of novel vitamin D receptor activator paricalcitol on renal ischaemia/reperfusion injury in rats, Ann R Coll Surg Engl, 95, 489, 10.1308/003588413X13629960049117 Goncalves, 2014, Vitamin D deficiency aggravates chronic kidney disease progression after ischemic acute kidney injury, PloS One, 9, 10.1371/journal.pone.0107228 de Braganca, 2015, Vitamin D deficiency aggravates ischemic acute kidney injury in rats, Physiol Rep, 3, 10.14814/phy2.12331 de Braganca, 2016, Vitamin D deficiency contributes to vascular damage in sustained ischemic acute kidney injury, Physiol Rep, 4, 10.14814/phy2.12829 Zapatero, 2018, Severe vitamin D deficiency upon admission in critically ill patients is related to acute kidney injury and a poor prognosis, Med Intensiva, 42, 216, 10.1016/j.medin.2017.07.004 Leaf, 2017, Fibroblast growth factor 23 levels associate with AKI and death in critical illness, J Am Soc Nephrol, 28, 1877, 10.1681/ASN.2016080836 Braun, 2012, Association of low serum 25-hydroxyvitamin D levels and acute kidney injury in the critically ill, Crit Care Med, 40, 3170, 10.1097/CCM.0b013e318260c928 Wolf, 2010, Forging forward with 10 burning questions on FGF23 in kidney disease, J Am Soc Nephrol, 21, 1427, 10.1681/ASN.2009121293 1989, The Atherosclerosis Risk in Communities (ARIC) study: design and objectives, Am J Epidemiol, 129, 687, 10.1093/oxfordjournals.aje.a115184 Lutsey, 2016, Short-term variability of vitamin D–related biomarkers, Clin Chem, 62, 1647, 10.1373/clinchem.2016.261461 Hollis, 2008, Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs, Am J Clin Nutr, 88, 507S, 10.1093/ajcn/88.2.507S Lutsey, 2015, The 25-hydroxyvitamin D3 C-3 epimer: distribution, correlates, and reclassification of 25-hydroxyvitamin D status in the population-based Atherosclerosis Risk in Communities study (ARIC), Clin Chim Acta, 442, 75, 10.1016/j.cca.2014.12.036 Grams, 2014, Performance and limitations of administrative data in the identification of AKI, Clin J Am Soc Nephrol, 9, 682, 10.2215/CJN.07650713 Inker, 2012, Estimating glomerular filtration rate from serum creatinine and cystatin C, N Engl J Med, 367, 20, 10.1056/NEJMoa1114248 Brown, 2014, Fibroblast growth factor-23 and the long-term risk of hospital-associated AKI among community-dwelling older individuals, Clin J Am Soc Nephrol, 9, 239, 10.2215/CJN.05830513 Ross AC, Taylor CL, Yaktine AL, Del Valle HB, eds. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press; 2011. Holick, 2011, Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, 96, 1911, 10.1210/jc.2011-0385 Grams, 2014, Identification of incident CKD stage 3 in research studies, Am J Kidney Dis, 64, 214, 10.1053/j.ajkd.2014.02.021 Nakano, 2012, Combined use of vitamin D status and FGF23 for risk stratification of renal outcome, Clin J Am Soc Nephrol, 7, 810, 10.2215/CJN.08680811 Achinger, 2005, The role of vitamin D in left ventricular hypertrophy and cardiac function, Kidney Int Suppl, S37, 10.1111/j.1523-1755.2005.09506.x Doorenbos, 2009, Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism, Nat Rev Nephrol, 5, 691, 10.1038/nrneph.2009.185 Kendrick, 2012, Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease, Am J Kidney Dis, 60, 567, 10.1053/j.ajkd.2012.04.014 Speer, 2015, A single preoperative FGF23 measurement is a strong predictor of outcome in patients undergoing elective cardiac surgery: a prospective observational study, Crit Care, 19, 190, 10.1186/s13054-015-0925-6 Ali, 2013, Preoperative plasma FGF23 levels predict acute kidney injury in children: results of a pilot study, Pediatr Nephrol, 28, 959, 10.1007/s00467-012-2395-2 Volovelsky, 2018, Pre-operative level of FGF23 predicts severe acute kidney injury after heart surgery in children, Pediatr Nephrol, 33, 2363, 10.1007/s00467-018-4024-1 Neyra, 2019, Urine Klotho is lower in critically ill patients with versus without acute kidney injury and associates with major adverse kidney events, Crit Care Explor, 1, 10.1097/CCE.0000000000000016 Smith, 2017, FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts, Sci Rep, 7, 3345, 10.1038/s41598-017-02709-w Silswal, 2014, FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability, Am J Physiol Endocrinol Metab, 307, E426, 10.1152/ajpendo.00264.2014 Singh, 2016, Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease, Kidney Int, 90, 985, 10.1016/j.kint.2016.05.019 Carpenter, 2014, Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia, J Clin Invest, 124, 1587, 10.1172/JCI72829 Ruppe, 2016, Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia, Bone Rep, 5, 158, 10.1016/j.bonr.2016.05.004 Vervloet, 2011, Effects of dietary phosphate and calcium intake on fibroblast growth factor-23, Clin J Am Soc Nephrol, 6, 383, 10.2215/CJN.04730510 Glosse, 2018, A high-fat diet stimulates fibroblast growth factor 23 formation in mice through TNFalpha upregulation, Nutr Diabetes, 8, 36, 10.1038/s41387-018-0037-x Manson, 2019, Vitamin D supplements and prevention of cancer and cardiovascular disease, N Engl J Med, 380, 33, 10.1056/NEJMoa1809944 National Heart, 2019, Early high-dose vitamin D3 for critically ill, vitamin D–deficient patients, N Engl J Med, 381, 2529, 10.1056/NEJMoa1911124 Michos, 2015, 25-hydroxyvitamin D levels, vitamin D binding protein gene polymorphisms and incident coronary heart disease among whites and blacks: the ARIC study, Atherosclerosis, 241, 12, 10.1016/j.atherosclerosis.2015.04.803 Lutsey, 2015, Race and vitamin D binding protein gene polymorphisms modify the association of 25-hydroxyvitamin D and incident heart failure: the ARIC (Atherosclerosis Risk in Communities) study, J Am Coll Cardiol HF, 3, 347 Hart, 2006, Measurement of vitamin D status: background, clinical use, and methodologies, Clin Lab, 52, 335